Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.26
-0.23 (-4.11%)
Aug 21, 2026, 4:08 PM HKT

HKG:0512 Cash Flow Statement

Millions HKD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,2412,4681,8802,0792,403
Depreciation & Amortization
581.9503.75392.21394.91339.52
Loss (Gain) From Sale of Assets
1.18113.060.181.55
Asset Writedown & Restructuring Costs
12.7644.750.1426.361.51
Loss (Gain) From Sale of Investments
128.38-675.93-89.2794.62-483.68
Loss (Gain) on Equity Investments
-76.06-148.7225.0143.79-113.86
Provision & Write-off of Bad Debts
39.6272.9857.7-22.6411.77
Other Operating Activities
64.4552.42219.23119.75144.97
Change in Accounts Receivable
-981.12-444.4-177.52-514.24-701.65
Change in Inventory
-51.8874.54-99.41-295.28-118.74
Change in Accounts Payable
583.63-174.31290.65-234.58605.5
Change in Unearned Revenue
94.88135.85-110.66154.96-64.09
Change in Other Net Operating Assets
10.93-12.17-26.24-3.78-19.67
Operating Cash Flow
1,6501,8982,4251,8432,006
Operating Cash Flow Growth
-13.10%-21.73%31.60%-8.13%37.76%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-726.15-555.78-487.73-626.22-471.57
Sale of Property, Plant & Equipment
2.760.976.611.9923.79
Cash Acquisitions
-321.83-1,179-176.42-269.22-245.41
Sale (Purchase) of Intangibles
-795.95-41.25-0.31-431.37-64.8
Investment in Securities
841.55-180.89-5.17-639.34-1,200
Other Investing Activities
32.12-41.78147.27-395.95142.42
Investing Cash Flow
-967.52-1,997-515.75-2,360-1,769

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
4,3454,4812,3703,1171,981
Long-Term Debt Repaid
-4,228-3,342-3,451-2,210-1,621
Net Debt Issued (Repaid)
116.271,139-1,081906.49359.6
Repurchase of Common Stock
---81.01-43.99-143.5
Common Dividends Paid
-910.47-910.47-496.94-390.45-390.45
Other Financing Activities
-157.34-198.26-230.08-145.05-158.82
Financing Cash Flow
-951.5429.96-1,889327-333.17

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
70.9270.56-124.06-118.4212.64
Net Cash Flow
-198.611.27-104.31-308.85-83.84

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
923.371,3421,9371,2161,534
Free Cash Flow Growth
-31.21%-30.71%59.25%-20.71%23.03%
Free Cash Flow Margin
7.52%11.53%18.40%12.72%17.84%
Free Cash Flow Per Share
0.260.380.550.340.43
Levered Free Cash Flow
-47.051,7541,544460.641,294
Unlevered Free Cash Flow
54.411,8661,672546.571,352

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
156.37180.24204.36137.4992.96
Cash Income Tax Paid
353.98480.24471.08349.26277.32
Change in Working Capital
-343.56-420.48-123.18-892.92-298.63